- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Superficial Bladder Cancer in Norway
Total 856 results
-
Jørgen Bjerggaard JensenNovo Nordisk A/S; University of AarhusRecruitingNon-muscle Invasive Bladder CancerDenmark, Norway, Latvia
-
The Hospital of VestfoldSouth-Eastern Norway Regional Health AuthorityCompletedOveractive BladderNorway
-
Norwegian School of Sport SciencesNorwegian Foundation for Health and Rehabilitation; The Norwegian Women´s Public...CompletedCystocele | Uterine Prolapse | Rectocele | Bladder DiseasesNorway
-
Norwegian University of Science and TechnologyCompletedCarcinoma, Basal Cell | Porokeratosis, Disseminated Superficial ActinicNorway
-
University of OsloLund University; University of Copenhagen; University of BergenCompletedAcute Cystitis (Excl in Pregnancy)Norway
-
National Cancer Institute (NCI)Radiation Therapy Oncology GroupCompletedBladder Urothelial Carcinoma | Stage I Bladder Cancer AJCC v6 and v7 | Stage II Bladder Cancer AJCC v6 and v7 | Stage III Bladder Cancer AJCC v6 and v7United States, Canada
-
Oslo University HospitalSunnaas Rehabilitation HospitalCompletedUrinary Bladder, Overactive | Spinal Cord InjuriesNorway
-
University of BergenNorwegian Extra Foundation for Health and Rehabilitation; Askøy MunicipalityCompleted
-
Coloplast A/SCompletedNeurogenic Bladder Dysfunction NosDenmark, France, Germany, Norway, Sweden
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor OveractivityBelgium, Denmark, Norway, Poland, Serbia
-
National Cancer Institute (NCI)Active, not recruitingBladder Urothelial Carcinoma | Stage IIIA Bladder Cancer AJCC v8 | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8United States
-
Göteborg UniversitySahlgrenska University Hospital, SwedenCompletedRadiation Induced Cystitis Treated With Hyperbaric Oxygen - A Randomized Controlled Trial (RICH-ART)Cystitis, Radio InducedSweden, Norway, Denmark, Finland
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Colombia, ... and more
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingUrinary Bladder Neoplasms | Muscle-Invasive Bladder CancerRussian Federation, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Finland, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Norway, Portugal, Roman... and more
-
Hoffmann-La RocheCompletedBladder CancerUnited States, France, Belgium, Korea, Republic of, United Kingdom, Czechia, Austria, Canada, Denmark, Greece, Italy, Netherlands, Portugal, Slovenia, Spain, Sweden, Turkey, Poland, Hungary, Switzerland, Japan, Taiwan, Australia, Norway, Germa... and more
-
AstraZenecaRecruitingMuscle Invasive Bladder CancerNetherlands, United Kingdom, Korea, Republic of, Canada, Germany, Italy, Poland, Spain, Turkey, Vietnam, Argentina, Japan, France, Brazil, Taiwan, United States, Israel, Austria, Chile, Colombia, Greece, Hong Kong, Mexico, Portugal, Russian... and more
-
PfizerCompletedOveractive BladderCzech Republic, Slovakia, United Kingdom, Sweden, Norway, Lithuania
-
Lovisenberg Diakonale HospitalUniversity of OsloRecruiting
-
Norwegian University of Science and TechnologyMedical University of Graz; Turku University Hospital; Oslo University Hospital; Rigshospitalet, Denmark and other collaboratorsCompleted
-
Oslo University HospitalRecruiting
-
Medical Research CouncilCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerCanada, United Kingdom, Norway, New Zealand, Netherlands, South Africa, Brazil, Finland
-
Haukeland University HospitalUnknownGynecologic CancerNorway
-
University Hospital, AkershusVestre Viken Hospital Trust; NovartisRecruitingBreast Cancer | Locally Advanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Luminal A Breast Cancer | Luminal B Breast CancerNorway
-
Nordic Society of Gynaecological Oncology - Clinical...Australia New Zealand Gynaecological Oncology GroupRecruitingGynaecological CancerNorway
-
Vestre Viken Hospital TrustRecruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Haraldsplass Deaconess HospitalUnknown
-
Oslo University HospitalRecruitingLocally Advanced Pelvic Cancer That Require Pelvic ExenterationNorway
-
Oslo University HospitalNorwegian Cancer SocietyCompleted
-
Oslo University HospitalActive, not recruiting
-
AstraZenecaCompletedMetastatic Breast CancerNorway
-
Haukeland University HospitalTerminatedColorectal Cancer Metastatic | Colorectal Cancer Stage IV | TP53 Gene MutationNorway
-
Vestre Viken Hospital TrustOdense University Hospital; Karolinska University Hospital; Oslo University Hospital and other collaboratorsRecruitingCancer | Lung Cancer | NSCLC Stage IV | Mutation | NSCLC, Stage III | Lung Cancer Stage IV | Cancer, LungNorway
-
Norwegian University of Science and TechnologyCompleted
-
University of BergenHaukeland University HospitalActive, not recruitingStage III Breast Cancer AJCC V7Norway
-
Haukeland University HospitalActive, not recruiting
-
University Hospital, AkershusRecruiting
-
Oslo University HospitalCompletedBreast Cancer SurgeryNorway
-
Ultimovacs ASAOslo University HospitalActive, not recruitingA Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer. (UV1-hTERT2012L)Non-small Cell Lung CancerNorway
-
Oslo University HospitalCompleted
-
Oslo University HospitalOslo Metropolitan UniversityRecruitingOral Cavity Cancer | Sinonasal CancerNorway
-
Cancer Registry of NorwayRecruitingHealth, Subjective | Breast Cancer PatientsNorway
-
Cancer Registry of NorwayExtrastiftelsenCompleted
-
Sorlandet Hospital HFUppsala University; University of AgderCompletedGynecologic CancerNorway
-
Haukeland University HospitalUppsala University; University of Bergen; University of AgderCompletedLymphoma | Breast Cancer | Colorectal Cancer | Prostate Cancer | Testicle CancerNorway
-
Oslo University HospitalSouth-Eastern Norway Regional Health AuthorityCompleted
-
Norwegian University of Science and TechnologySt. Olavs HospitalActive, not recruiting
-
Norwegian University of Science and TechnologySt. Olavs HospitalTerminatedBreast Cancer | Prostate CancerNorway
-
The Nordic Colorectal Cancer Biomodulation GroupCompletedMetastatic Colorectal CancerNorway